| Record ID | marc_university_of_toronto/uoft.marc:1258885737:999 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:1258885737:999?format=raw |
LEADER: 00999cam 2200253 a 4500
005 19951218153517.4
008 951218s1994 sz a b 000 0 eng d
020 $a3907770161
050 4 $aRL120.R48$bH37 1994
060 04 $aWR 430$bH288s 1989
090 8 $aRL 120 .R48H37 1994$bGERSTM$c1
100 1 $aHarms, Monika.
245 10 $aSystemic isotretinoin (active ingredient of Roaccutane) :$ba unique therapeutic effect and its implications in the pathogenesis of acne /$cby Monika Harms.
250 $a3rd ed.
260 $aBasel, Switzerland :$bEditiones Roche,$c1994.
300 $a93 p. :$bill. (some col.)
504 $aIncludes bibliographical references (p. 84-93)
650 0 $aAcne$xChemotherapy.
650 0 $aIsotretinoin.
650 0 $aRetinoids$xTherapeutic use.
650 0 $aSkin$xDiseases$xChemotherapy.
948 $a12/18/1995$b08/06/2001
039 $fmc/mc(mc)
949 $aRL120 .R48 H37 1994$wLC$c1$i31761041932443$d6/12/2006$e26/11/2006$lSTACKS$mGERSTEIN$n14$q9$rY$sY$tBOOK$u20/12/1995